Published: 2017-09-18 BioNTech IMFS Expands Production Capacities To prepare for further growth in demand for cell and gene therapy products, e.g. for CAR-T and T-Cell immunotherapies, BioNTech Innovative Manufacturing Services will significantly increase its... Read more
Published: 2017-09-18 EUFETS Becomes BioNTech Innovative Manufacturing Services BioNTech AG, announced on October 1st, 2017 that its manufacturing subsidiary EUFETS GmbH has been re-branded BioNTech Innovative Manufacturing Services. BioNTech Innovative Manufacturing... Read more
Published: 2017-09-18 20 years of passion for Cell and Gene Therapy Manufacturing EUFETS, now BioNTech IMFS, celebrates twenty years of uninterrupted service to the cell and gene therapy community. When our company was founded in 1997 with only seven employees, we could hardly... Read more